Search

everythinglearnresearchcommunity

for

Search:↓

Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Experts made a guide to help doctors evaluate women with too much hair growth.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Low estrogen compared to androgen may cause female hair loss.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

FFA in young women is often missed, and no single treatment works best.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Isotretinoin may cause temporary, reversible facial hair growth in some women.